ALTSHULER DAVID 4

4 · VERTEX PHARMACEUTICALS INC / MA · Filed Feb 12, 2025

Insider Transaction Report

Form 4
Period: 2025-02-10
ALTSHULER DAVID
EVP, Chief Scientific Officer
Transactions
  • Tax Payment

    Common Stock

    2025-02-10$467.98/sh2,142$1,002,41343,099 total

Documents

1 file
  • 4
    wk-form4_1739395266.xmlPrimary

    FORM 4